Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or Plasmacytoma
Clinical trial NCT06429150 · RECRUITING
Trial details
- NCT number
- NCT06429150
- Sponsor
- Shenzhen Geno-Immune Medical Institute
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-11
- Primary completion
- 2027-07-11
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.